Importance of Therapeutic Drug Monitoring to Detect Drug Interaction between Pazopanib and Warfarin: A Case Report

Importance of Therapeutic Drug Monitoring to Detect Drug Interaction between Pazopanib and Warfarin: A Case Report

Pazopanib is an orally available multi-tyrosine kinase inhibitor and has been used to treat renal cell carcinoma (RCC). Here, we report the case of a patient with RCC with an increased prothrombin time-international normalized ratio (PT-INR) due to pazopanib therapy. In addition, we have reported th...

Full description

Bibliographic Details
Main Authors:	Shinya Takasaki, Hisanobu Adachi, Yoshihide Kawasaki, Masafumi Kikuchi, Akihiro Ito, Nariyasu Mano
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-05-01
Series:	Journal of Pharmacy & Pharmaceutical Sciences
Online Access:	https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/30868

Similar Items

Clinical Importance of Plasma Drug Concentration of Oral Molecular Targeted Drugs for Renal Cell Carcinoma
by: Shinya Takasaki, et al.
Published: (2021-03-01)

Elucidation and Regulation of Tyrosine Kinase Inhibitor Resistance in Renal Cell Carcinoma Cells from the Perspective of Glutamine Metabolism
by: Kento Morozumi, et al.
Published: (2024-03-01)

Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitators
by: Kim Westerdijk, et al.
Published: (2023-11-01)

High throughput LC/ESI-MS/MS method for simultaneous analysis of 20 oral molecular-targeted anticancer drugs and the active metabolite of sunitinib in human plasma
by: Tensei Hirasawa, et al.
Published: (2023-06-01)

A Case of an Increase in Prothrombin Time-International Normalized Ratio by Interaction Between Warfarin and Baloxavir Marboxil in a Patient on Implantable Ventricular Assist Device
by: Keiko Kurosawa, et al.
Published: (2021-01-01)

Birth Outcomes of Anticancer Drug Prescriptions during Pregnancy: A Case Series from a Japanese Claims Database
by: Kentaro Tajima, et al.
Published: (2023-01-01)

Wide-Targeted Semi-Quantitative Analysis of Acidic Glycosphingolipids in Cell Lines and Urine to Develop Potential Screening Biomarkers for Renal Cell Carcinoma
by: Masamitsu Maekawa, et al.
Published: (2024-04-01)

Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury
by: Maud Maillard, et al.
Published: (2022-09-01)

Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor
by: Dave Yong Xiang Ng, et al.
Published: (2022-04-01)

Case report: Medical cannabis—warfarin drug-drug interaction
by: Tyan F. Thomas, et al.
Published: (2022-01-01)

Bile Acid–Drug Interaction via Organic Anion-Transporting Polypeptide 4C1 Is a Potential Mechanism of Altered Pharmacokinetics of Renally Excreted Drugs
by: Minami Yamauchi, et al.
Published: (2022-07-01)

Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma
by: Filipa Amaro, et al.
Published: (2022-04-01)

Warfarin and Antibiotics: Drug Interactions and Clinical Considerations
by: Alexis J. Vega, et al.
Published: (2023-07-01)

Warfarin: pharmacological profile and drug interactions with antidepressants
by: Juliana Souto Teles, et al.
Published: (2012-03-01)

Importance of Therapeutic Drug Monitoring of Immunosuppressant Drugs Using Cost-Effective Analytical Methods
by: Emilya Zakir Balayeva, et al.
Published: (2021-12-01)

Assessment of Information Sharing on Adverse Drug Reactions by Community Pharmacies with Other Medical Institutions
by: Daisuke Kikuchi, et al.
Published: (2022-02-01)

Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report)
by: N. T. Vatutin, et al.
Published: (2020-03-01)

Story of warfarin: From rat poison to lifesaving drug
by: Sreekumar Ramachandran, et al.
Published: (2018-01-01)

Evaluation of adverse drug reaction in patients warfarin therapy
by: Norisca Aliza Putriana, et al.
Published: (2022-01-01)

Warfarin therapy in patients with coronary heart disease and atrial fibrillation: drug interactions and genetic sensitivity to warfarin
by: O. A. Panibratiuk, et al.
Published: (2020-06-01)

HPLC-MS/MS coupled with equilibrium dialysis method for quantification of free drug concentration of pazopanib in plasma
by: Toh, Yi Long, et al.
Published: (2020)

Organic Anion Transporting Polypeptides 1B1 and 1B3 Play an Important Role in Uremic Toxin Handling and Drug-Uremic Toxin Interactions in the Liver
by: Toshihiro Sato, et al.
Published: (2014-10-01)

Therapeutic drug monitoring : newer drugs and biomarkers /
by: Dasgupta, Amitava, 1958-
Published: (2012)

Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas
by: Eduardo J. Medina, et al.
Published: (2023-07-01)

Influence of two anti-tumor drugs, pazopanib, and axitinib, on the development and thyroid-axis of zebrafish (Danio rerio) embryos/larvae
by: Liu Yang, et al.
Published: (2023-07-01)

Determining the effect of drug "Warfarin sodium" on toxicity indicators in an acute experiment
by: D.O. Hlavachek, et al.
Published: (2023-09-01)

Proteomics and metabolomics analysis of cellular response to anti-coagulating drug warfarin
by: Bai, Jing
Published: (2011)

Limited Sampling Strategy for the Estimation of Mycophenolic Acid and its Acyl Glucuronide Metabolite Area under the Concentration-Time Curve in Japanese Lung Transplant Recipients
by: Masaki Tanaka, et al.
Published: (2019-08-01)

Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs
by: Prso K, et al.
Published: (2020-08-01)

THE ROLE OF THE THERAPEUTIC DRUG MONITORING WHEN USING ANTIEPILEPTIC DRUGS
by: A. V. Yakunina, et al.
Published: (2016-12-01)

Pazopanib in the treatment of advanced renal cell carcinoma
by: M. I. Volkova, et al.
Published: (2018-11-01)

A rare case: Mania associated with pazopanib
by: Bryan Ling Wei Tan, et al.
Published: (2022-12-01)

Rare case of rapid hair depigmentation with Pazopanib
by: Ephraïm Lonté Kintossou, et al.
Published: (2023-01-01)

Preparation and Characterization of Pazopanib Hydrochloride-Loaded Four-Component Self-Nanoemulsifying Drug Delivery Systems Preconcentrate for Enhanced Solubility and Dissolution
by: Seung Ah Choi, et al.
Published: (2022-09-01)

Therapeutic Drug Monitoring in Arterial Hypertension
by: Sergey Seleznev, et al.
Published: (2023-05-01)

Bleeding Following Warfarin and Amoxicillin/Clavulanate Drug Interaction: A Case Report
by: Saeed Kargar-soleimanabad, et al.
Published: (2023-10-01)

Proteomics analysis of cells incubated with R-enantiomer of warfarin, an anti-coagulating drug
by: Teo, Kathrine Wei Shi.
Published: (2009)

Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease
by: Toshiya Machida, et al.
Published: (2022-07-01)

WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT
by: S. Yu. Martsevich, et al.
Published: (2017-11-01)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs
by: Yao Liu, et al.
Published: (2022-10-01)